317 related articles for article (PubMed ID: 31254522)
1. A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain.
Dessie SG; Von Bargen E; Hacker MR; Haviland MJ; Elkadry E
Am J Obstet Gynecol; 2019 Nov; 221(5):517.e1-517.e9. PubMed ID: 31254522
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain.
Adelowo A; Hacker MR; Shapiro A; Modest AM; Elkadry E
Female Pelvic Med Reconstr Surg; 2013; 19(5):288-92. PubMed ID: 23982578
[TBL] [Abstract][Full Text] [Related]
3. Botulinum Toxin A Injections Into Pelvic Floor Muscles Under Electromyographic Guidance for Women With Refractory High-Tone Pelvic Floor Dysfunction: A 6-Month Prospective Pilot Study.
Morrissey D; El-Khawand D; Ginzburg N; Wehbe S; O'Hare P; Whitmore K
Female Pelvic Med Reconstr Surg; 2015; 21(5):277-82. PubMed ID: 25900057
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
[TBL] [Abstract][Full Text] [Related]
5. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
[TBL] [Abstract][Full Text] [Related]
6. OnabotulinumtoxinA Injections for the Treatment of Myofascial Pelvic Pain: 12-Year Experience at a Tertiary Care Academic Center.
Lewis GK; Carrubba AR; Stanton AP; Craver EC; Li Z; Chen AH
Gynecol Obstet Invest; 2023; 88(1):37-46. PubMed ID: 36577396
[TBL] [Abstract][Full Text] [Related]
7. Botox combined with myofascial release physical therapy as a treatment for myofascial pelvic pain.
Halder GE; Scott L; Wyman A; Mora N; Miladinovic B; Bassaly R; Hoyte L
Investig Clin Urol; 2017 Mar; 58(2):134-139. PubMed ID: 28261683
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin infiltrations versus local anaesthetic infiltrations in pelvic floor myofascial pain: Multicentre, randomized, double-blind study.
Levesque A; Ploteau S; Michel F; Siproudhis L; Bautrant E; Eggermont J; Rabischong B; Volteau C; Perrouin-Verbe MA; Labat JJ
Ann Phys Rehabil Med; 2021 Jan; 64(1):101354. PubMed ID: 31981833
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
[TBL] [Abstract][Full Text] [Related]
10. Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A.
Ferrante FM; Bearn L; Rothrock R; King L
Anesthesiology; 2005 Aug; 103(2):377-83. PubMed ID: 16052120
[TBL] [Abstract][Full Text] [Related]
11. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
Ojala T; Arokoski JP; Partanen J
Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Botulinum Toxin for Treatment of Symptomatic Pelvic Floor Myofascial Pain in Women: A Systematic Review and Meta-analysis.
Meister MR; Brubaker A; Sutcliffe S; Lowder JL
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e152-e160. PubMed ID: 32301801
[TBL] [Abstract][Full Text] [Related]
13. Concurrent Retropubic Midurethral Sling and OnabotulinumtoxinA for Mixed Urinary Incontinence: A Randomized Controlled Trial.
Komar A; Bretschneider CE; Mueller MG; Lewicky-Gaupp C; Collins S; Geynisman-Tan J; Tavathia M; Kenton K
Obstet Gynecol; 2021 Jan; 137(1):12-20. PubMed ID: 33278293
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.
Nicol AL; Wu II; Ferrante FM
Anesth Analg; 2014 Jun; 118(6):1326-35. PubMed ID: 24842179
[TBL] [Abstract][Full Text] [Related]
15. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
[TBL] [Abstract][Full Text] [Related]
16. Magnesium-Based Trigger Point Infiltrations Versus Local Anaesthetic Infiltrations in Chronic Pelvic Myofascial Pain: A Randomized, Double-Blind, Controlled Study.
Leitch J; Webb A; Pudwell J; Chamberlain S; Henry R; Nitsch R
J Obstet Gynaecol Can; 2022 Aug; 44(8):877-885. PubMed ID: 35339694
[TBL] [Abstract][Full Text] [Related]
17. An update on botulinum toxin A injections of trigger points for myofascial pain.
Zhou JY; Wang D
Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
[TBL] [Abstract][Full Text] [Related]
18. Botulinum injections for myofascial pelvic pain.
Jha S; Toozs-Hobson P; Roper JC; Gurung S; Brair A; Bach F
Int Urogynecol J; 2021 May; 32(5):1151-1156. PubMed ID: 32696187
[TBL] [Abstract][Full Text] [Related]
19. Effect of Vaginal Stretching and Photobiomodulation Therapy on Sexual Function in Women With Pelvic Floor Myofascial Pain - A Randomized Clinical Trial.
Frederice CP; de Mira TAA; Machado HC; Brito LGO; Juliato CRT
J Sex Med; 2022 Jan; 19(1):98-105. PubMed ID: 34955173
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of PrabotulinumtoxinA (Nabota
Kim DY; Kim JM
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30177597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
